Gyldendal ASA (OSL:GYL)
Norway
· Delayed Price · Currency is NOK 426.00
0.00 (0.00%)
Apr 28, 2026, 4:07 PM CET
Gyldendal ASA Revenue
In the year 2025, Gyldendal ASA had annual revenue of 2.92B NOK with 6.80% growth. Gyldendal ASA had revenue of 1.77B in the half year ending December 31, 2025, with 9.57% growth.
Revenue
2.92B
Revenue Growth
+6.80%
P/S Ratio
0.34
Revenue / Employee
1.91M
Employees
1,694
Market Cap
982.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.92B | 185.78M | 6.80% |
| Dec 31, 2024 | 2.73B | 44.97M | 1.67% |
| Dec 31, 2023 | 2.69B | 8.43M | 0.31% |
| Dec 31, 2022 | 2.68B | 156.82M | 6.22% |
| Dec 31, 2021 | 2.52B | 177.24M | 7.56% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vistin Pharma ASA | 449.47M |
| S.D. Standard ETC | 46.09M |
| Saga Pure ASA | 29.69M |
| Jacktel AS | 705.78M |
| ArcticZymes Technologies ASA | 118.21M |
| Norsk Titanium AS | 34.87M |
| Nykode Therapeutics AS | 4.57M |
| Lumi Gruppen AS | 506.53M |